Dr. Cristy Kessler is a motivational speaker, author, a tenured professor in University of Hawaii and a survivor. For the first 26 years of her life, Dr. Kessler has been in chronic pain and fatigue and in 2007 she was diagnosed with three rare autoimmune diseases: scleroderma, ankylosing spondylitis, and vasculitis. She received several treatments and medications in the different hospitals in the US which, apparently, did not seem to be a success because they were only treating the symptoms not the disease itself.
Because of this, Dr. Kessler, together with her rheumatologist, decided that she finds other healthcare options for her illness and made a choice to live. In 2011, she traveled to Istanbul, Turkey to receive stem cell transplant which literally saved and changed her life.
Find out more of this inspiring story!
Thank you for listening. We would appreciate your comments and reviews
In This Episode, You’ll Learn
- About Dr. Cristy Kessler’s 26 years of struggle in chronic pain and fatigue
- About the three autoimmune diseases that attacked her simultaneously
- How she saw several doctors and underwent different procedures hoping it could treat the disease.
- How she was disapproved by the FDA to receive SCT despite of her autoimmune diseases because she did not fit into the FDA sanctioned research study.
- That after several treatments, she decided to travel to Istanbul to receive stem cell transplants in 2011
- How her expertise and experience inspired her to design and author her book “5 S.T.E.P.S to Being Your Own Patient Advocate”
- Dr. Cristy Kessler’s Website
- Facebook Account
- LinkedIn Profile
- Youtube Channel: “Dr. Cristy Kessler How Do We Teach Thinking”
- Youtube Channel: “UH Professor Diagnosed with 3 Rare Diseases”
- Dr. Cristy Kessler’s Blog
- Contact Info
- Dr. Cristy Kessler’s “5 S.T.E.P.S to Being Your Own Patient Advocate”
The Onwards Medical Breakthrough
Human skin cells reprogrammed directly into brain cells
“Scientists have described a way to convert human skin cells directly into a specific type of brain cell affected by Huntington’s disease, an ultimately fatal neurodegenerative disorder. Unlike other techniques that turn one cell type into another, this new process does not pass through a stem cell phase, avoiding the production of multiple cell types, the study’s authors report.”
“The researchers, at Washington University School of Medicine in St. Louis, demonstrated that these converted cells survived at least six months after injection into the brains of mice and behaved similarly to native cells in the brain.”
You can learn more about this discovery at this link.